Send me a link:

*Text messaging rates may apply.

 Dow Down 0.28% Nasdaq Down 0.17%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS
13.00 0.15(1.17%) Jul 21, 4:00PM EDT
Prev Close:12.85
Open:12.70
Bid:13.00 x 1000
Ask:13.53 x 500
1y Target Est:36.29
Beta:3.17
Next Earnings Date: 6-Aug-14CLDX Earnings announcement
Day's Range:12.46 - 13.19
52wk Range:10.76 - 38.84
Volume:1,468,100
Avg Vol (3m):2,490,860
Market Cap:1.16B
P/E (ttm):N/A
EPS (ttm):-1.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLDX

Comparison

Symbol% ChgMkt Cap
CLDXUp 1.17%1.16B
DNDN331.94M
LLY68.27B
RHHBY249.41B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):543.42
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.32
Quarterly EPS Est (Jun-14) :-0.32
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback